Polio vaccine – what you need to know

Published May 19, 2014
- File photo
- File photo

ISLAMABAD: As more and more would-be travellers queue up at hospitals and immunisation centres across the country for their dose of the polio vaccine, many have concerns about the vaccine’s safety and the proper dosage for children and adults alike.


WHO recommends drops in tandem with IPV injections for children; patients with compromised immune systems must be administered IPV only


Currently, there are two kinds of polio vaccine available, oral poliovirus vaccine (OPV) or polio drops, and the inactivated poliovirus vaccine (IPV), which is administered via intramuscular injection – usually a shot in the arm.

According to the World Health Organisation’s Position Paper on Polio Vaccines (February 2014), which lays down the latest international guidelines for immunisation against the disease, WHO no longer recommends OPV-only vaccination. For all countries currently using OPV-only, at least one dose of IPV should be added to the schedule.

This position paper also serves as the background document for a recently issued advisory from the Ministry of National Health Services (MNHS), which is supposed to serve as the guiding document for vaccination in the country.

In polio endemic countries and in countries at high risk for importation and subsequent spread (such as Pakistan), WHO recommends an OPV birth dose followed by a series of three OPV doses and at least one IPV dose.

Making specific reference to Pakistan, the position paper states: “In Pakistan, a comparison of the serological responses to various OPV or IPV schedules, or combined schedules, confirmed a favourable immunological response to combined IPV+OPV vaccination.”

But while WHO maintains that all children worldwide should be fully vaccinated against polio, doctors warn that individuals with certain medical conditions should seek medical advice before being vaccinated.

Contraindications

The MNHS advisory takes care to identify cases where OPV is not recommended.

Dr Tabish Hazir, head of paediatrics at the Children’s Hospital of the Pakistan Institute of Medical Sciences (Pims), told Dawn that in certain cases, OPVs were contraindicated. In patients with certain pre-existing conditions that compromise the immune system OPVs can have negative side-effects.

“People who are severely immuno-compromised may be at risk if they are administered liquid polio drops. The OPV contains a weakened poliovirus which, in rare cases, has been known to cause polio paralysis in individuals with weakened immune systems,” he said.

In addition, people infected with the human immunodeficiency virus (HIV) could also face similar side effects.

“Due to a prevailing social taboo around HIV-Aids, people usually do not want to disclose the fact that they have the disease. But fortunately, the number of HIV-Aids affected individuals in Pakistan is quite low,” he said. OPV is also not recommended for cancer patients who have been undergoing chemotherapy. Radiation therapy also weakens the immune system, rendering patients more susceptible to even the weakest infections.

“In addition, those prescribed Corticosteroids may be at risk, because steroids can also activate weakened viruses,” Dr Hazir said.

Dr Hazir revealed that patients suffering from Thymus Disorder should not be administered OPVs. The thymus is a specialised organ of the immune system and those afflicted with this disorder tend to get sick quite often.

IPV: A Safe Alternative

Dr Tabish said that people with such diseases should be given Inactivated Polio Vaccine (IPV) which is given by intramuscular injection.

“IPV is not a live vaccine as the poliovirus used is deactivated. Therefore, it carries no risk of vaccine-associated polio paralysis. However, IPV is more expensive and needs to be administered by a trained health worker,” he said.

This view is supported by the WHO position paper, which states: “IPV is considered very safe, whether given alone or in combination with other vaccines. There is no proven causal relationship to any adverse events”.

Dr Mulazim Hussain, director of the polio counter at Pims, told Dawn steps were being taken to inform the public of these precautions.

However, when asked if IPV was available at Pims, he said: “It is very expensive and people who need to be administered IPV should buy it on their own”.

Published in Dawn, May 19th, 2014

Opinion

Merging for what?

Merging for what?

The concern is that if the government is thinking of cutting costs through the merger, we might even lose the functionality levels we currently have.

Editorial

Dubai properties
Updated 16 May, 2024

Dubai properties

It is hoped that any investigation that is conducted will be fair and that no wrongdoing will be excused.
In good faith
16 May, 2024

In good faith

THE ‘P’ in PTI might as well stand for perplexing. After a constant yo-yoing around holding talks, the PTI has...
CTDs’ shortcomings
16 May, 2024

CTDs’ shortcomings

WHILE threats from terrorist groups need to be countered on the battlefield through military means, long-term ...
Reserved seats
Updated 15 May, 2024

Reserved seats

The ECP's decisions and actions clearly need to be reviewed in light of the country’s laws.
Secretive state
15 May, 2024

Secretive state

THERE is a fresh push by the state to stamp out all criticism by using the alibi of protecting national interests....
Plague of rape
15 May, 2024

Plague of rape

FLAWED narratives about women — from being weak and vulnerable to provocative and culpable — have led to...